{"id":8218,"date":"2017-11-21T19:02:37","date_gmt":"2017-11-21T18:02:37","guid":{"rendered":"https:\/\/www.neurosciences.asso.fr\/2017\/11\/les-recepteurs-synaptiques-mglur5-en-mouvement-fauteurs-de-troubles-dans-le-syndrome-du-x-fragile\/"},"modified":"2017-11-21T19:02:37","modified_gmt":"2017-11-21T18:02:37","slug":"les-recepteurs-synaptiques-mglur5-en-mouvement-fauteurs-de-troubles-dans-le-syndrome-du-x-fragile","status":"publish","type":"post","link":"https:\/\/www.neurosciences.asso.fr\/en\/2017\/11\/les-recepteurs-synaptiques-mglur5-en-mouvement-fauteurs-de-troubles-dans-le-syndrome-du-x-fragile\/","title":{"rendered":"Les r\u00e9cepteurs synaptiques mGluR5 en mouvement : fauteurs de troubles dans le syndrome du X fragile"},"content":{"rendered":"<p>Le syndrome du X fragile (SXF) est la forme h\u00e9r\u00e9ditaire la plus courante de d\u00e9ficience intellectuelle et une cause fr\u00e9quente de troubles du spectre autistique (TSA). Le sous-type 5 du r\u00e9cepteur m\u00e9tabotropique au glutamate (mGluR5) est crucial dans la physiopathologie du SXF. Cependant, son dysfonctionnement au niveau subcellulaire par rapport aux ph\u00e9notypes synaptiques et cognitifs du SXF est largement inexplor\u00e9. mGluR5 s\u2019associe avec un certain nombre de prot\u00e9ines synaptiques et ces interactions influencent fortement les propri\u00e9t\u00e9s dynamiques du r\u00e9cepteur \u00e0 la synapse, ainsi que la fonction d\u2019autres r\u00e9cepteurs membranaires.<\/p>\n<p>Des travaux ant\u00e9rieurs ont d\u00e9montr\u00e9 que l&#8217;interaction entre mGluR5 et les formes longues de la prot\u00e9ine d&#8217;\u00e9chafaudage, Homer, est r\u00e9duite chez les souris d\u00e9ficientes pour le g\u00e8ne Fmr1 (mod\u00e8le murin pour SXF) et que ces alt\u00e9rations sont caus\u00e9es par une surexpression de Homer1a, l&#8217;une des isoformes d&#8217;Homer. Les cons\u00e9quences de cette interaction alt\u00e9r\u00e9e pour la dynamique des r\u00e9cepteurs n&#8217;avaient cependant pas \u00e9t\u00e9 \u00e9tudi\u00e9es auparavant.<\/p>\n<p>Dans cette \u00e9tude, nous avons sond\u00e9 les cons\u00e9quences de la perturbation du complexe contenant mGluR5\/Homer pour la mobilit\u00e9 de mGluR5 \u00e0 la surface cellulaire, pour la fonction synaptique du r\u00e9cepteur N-m\u00e9thyl-D-aspartate (NMDAR) et pour les ph\u00e9notypes comportementaux chez les souris Fmr1 -\/y.<\/p>\n<p>Par le suivi d\u2019une mol\u00e9cule unique, nous avons trouv\u00e9 que mGluR5 \u00e9tait significativement plus mobile aux synapses des neurones Fmr1-\/y de l\u2019hippocampe, provoquant une augmentation\u00a0 de la co-localisation \u00e0 la surface synaptique de mGluR5 et NMDAR. Ceci est corr\u00e9l\u00e9 avec une diminution de l&#8217;amplitude des courants synaptiques li\u00e9e au NMDAR, \u00e0 l&#8217;absence de leur d\u00e9pression \u00e0 long terme activ\u00e9e par mGluR5 et \u00e0 des d\u00e9ficits cognitifs NMDAR \/ hippocampe. Ces ph\u00e9nom\u00e8nes synaptiques et comportementaux ont \u00e9t\u00e9 invers\u00e9s en inhibant l\u2019expression de l\u2019isoforme courte Homer1a, dans l&#8217;hippocampe des souris Fmr1 -\/y.<\/p>\n<p>Notre \u00e9tude fournit un important lien m\u00e9canistique entre les changements dans la dynamique de mGluR5 aux sites synaptiques et les ph\u00e9notypes pathologiques du SXF. Ces d\u00e9couvertes sont susceptibles d\u2019avoir des cons\u00e9quences importantes pour le futur d\u00e9veloppement d\u2019agents \/ strat\u00e9gies th\u00e9rapeutiques du SXF.<\/p>\n<p>En effet, mGluR5 et NMDAR ont \u00e9t\u00e9 propos\u00e9s comme cibles th\u00e9rapeutiques dans le SXF et le lien entre ces deux r\u00e9cepteurs devrait \u00eatre pris en compte lors de la pr\u00e9diction des r\u00e9sultats de th\u00e9rapies unique ou combin\u00e9e. De plus, la correction de l\u2019\u00e9quilibre alt\u00e9r\u00e9 entre mGLluR5\/Homer et mGluR5\/NMDAR pourrait constituer une alternative th\u00e9rapeutique prometteuse pour le d\u00e9veloppement de nouveaux agents th\u00e9rapeutiques pour le traitement du SXF et des TSA.<\/p>\n<p>R\u00e9f\u00e9rence\u00a0:<\/p>\n<p>Aloisi E, Le Corf K, Dupuis J, Zhang P, Ginger M, Labrousse V, Spatuzza M, Georg Haberl M, Costa L, Shigemoto R, Tappe-Theodor A, Drago F, Vincenzo Piazza P, Mulle C, Groc L, Ciranna L, Catania MV, Frick A. Altered surface mGluR5 dynamics provoke synaptic NMDAR dysfunction and cognitive defects in Fmr1 knockout mice. Nat Commun. 2017 Oct 24;8(1):1103. doi: 10.1038\/s41467-017-01191-2.<\/p>\n<p>Contact\u00a0:<\/p>\n<p>Andreas Frick, Neurocentre Magendie, INSERM U1215, 146 rue L\u00e9o Saignat, 33077 Bordeaux Cedex<br \/>\n<a href=\"mailto:andreas.frick@inserm.fr\">Courriel<\/a><\/p>\n<p>&nbsp;<\/p>\n<p>Fragile X syndrome (FXS) is the most common inherited form of intellectual disability and a frequent cause of autism spectrum disorder (ASD). Metabotropic glutamate receptor subtype 5 (mGluR5) is crucially implicated in the pathophysiology of FXS. However, its dysfunction at the sub-cellular level in relation to the synaptic and cognitive phenotypes in FXS is largely unexplored. mGluR5 associates with a number of synaptic proteins and these interactions strongly influence the dynamic properties of the receptor at the synapse, as well as the function of other membrane receptors. Previous work has demonstrated that the interaction between mGluR5 and long forms of the scaffolding protein, Homer, is reduced in Fmr1 knockout mice (the mouse model for FXS) and that these alterations are caused by an overexpression of the short, activity-regulated Homer isoform, Homer 1a. The consequences of this altered interaction for receptor dynamics had not, however, been previously investigated.<\/p>\n<p>In this study, we probed the consequences of the aforementioned mGluR5\/Homer scaffold disruption for mGluR5 cell-surface mobility, synaptic N-methyl-D-aspartate receptor (NMDAR) function, and behavioral phenotypes in the Fmr1 knockout (KO) mouse. Using single-molecule tracking, we found that individual mGluR5 was significantly more mobile at synapses in hippocampal Fmr1KO neurons, causing an increased synaptic surface co-clustering of mGluR5 and NMDAR. This correlated with reduced amplitude of synaptic NMDAR currents, a lack of their mGluR5-activated long-term depression, and NMDAR\/hippocampus dependent cognitive deficits. Crucially, these synaptic and behavioral phenomena were reversed by knocking down the short, activity-related Homer1a in the hippocampus of Fmr1 KO mice. Our study provides an important mechanistic link between changes in mGluR5 dynamics at synaptic sites and pathological phenotypes of FXS. These findings are likely to have important consequences for the future development of therapeutic agents\/strategies for the treatment of FXS. In particular, both mGluR5 and NMDAR have been proposed as targets for therapeutic intervention in FXS and this altered crosstalk between these two receptors should be taken into consideration when predicting the outcome of single or combined therapies. In addition, correcting the altered balance between GluR5\/Homer and mGluR5\/NMDAR might provide a promising alternative for the development of novel therapeutic agents for the treatment of FXS and ASD.<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Le syndrome du X fragile (SXF) est la forme h\u00e9r\u00e9ditaire la plus courante de d\u00e9ficience intellectuelle et une cause fr\u00e9quente de troubles du spectre autistique (TSA). Le sous-type 5 du r\u00e9cepteur m\u00e9tabotropique au glutamate (mGluR5) est crucial dans la physiopathologie du SXF. Cependant, son dysfonctionnement au niveau subcellulaire par rapport aux ph\u00e9notypes synaptiques et cognitifs [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":8213,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[25],"tags":[31],"class_list":["post-8218","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized","tag-actualite-en"],"publishpress_future_action":{"enabled":false,"date":"2026-04-22 09:02:26","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/www.neurosciences.asso.fr\/en\/wp-json\/wp\/v2\/posts\/8218","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.neurosciences.asso.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.neurosciences.asso.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.neurosciences.asso.fr\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.neurosciences.asso.fr\/en\/wp-json\/wp\/v2\/comments?post=8218"}],"version-history":[{"count":0,"href":"https:\/\/www.neurosciences.asso.fr\/en\/wp-json\/wp\/v2\/posts\/8218\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.neurosciences.asso.fr\/en\/wp-json\/wp\/v2\/media\/8213"}],"wp:attachment":[{"href":"https:\/\/www.neurosciences.asso.fr\/en\/wp-json\/wp\/v2\/media?parent=8218"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.neurosciences.asso.fr\/en\/wp-json\/wp\/v2\/categories?post=8218"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.neurosciences.asso.fr\/en\/wp-json\/wp\/v2\/tags?post=8218"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}